Neurobiology of Opioid Dependence: 2 - 2

• Status: Withdrawn
• Trial end date: 1998-01-01
• Target enrollment: 0
• Participant gender: Male

Summary

The purpose of this study is to evaluate the effects of gamma hydroxybutyric on naloxone-precipitated opiate withdrawal.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Yale University
• Collaborator: National Institute on Drug Abuse (NIDA)
• Treatments: Analgesics, Opioid

Criteria

Please contact site for information.